A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) | MicrobiomeTrials← Back to trialsNCT07545759
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-06Est. Completion: 2027-09
Enrollment target: 531 participants Locations- Del Sol Research Management - Mesa, Mesa, Arizona, United States
- Smart Cures Clinical Research, Anaheim, California, United States
- Om Research LLC, Lancaster, California, United States
- United Medical Doctors - Los Alamitos, Los Alamitos, California, United States
- Encore Medical Research, Hollywood, Florida, United States
- Clinical Research of Osceola, Kissimmee, Florida, United States
- Springfield Clinic - First, Springfield, Illinois, United States
- Gastroenterology Health Partners, New Albany, Indiana, United States
- Gastroenterology Health Partners, Louisville, Kentucky, United States
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming, Michigan, United States
- Mayo Clinic in Rochester, Minnesota, Rochester, Minnesota, United States
- Ohio Gastroenterology, Columbus, Ohio, United States
- University Gastroenterology, Providence, Rhode Island, United States
- Biopharma Informatic, LLC, McAllen, Texas, United States
- Southern Star Research Institute, San Antonio, Texas, United States
Other microbiome trials you might be interested in
FibromyalgiaDiet, Gluten-Free
The purpose of this study is to evaluate the efficacy of two diets - gluten-free and low-FODMAP diet- in relieving sympt…
Montreal, CanadaCompleted Jun 15, 2022
ConstipationProbioticProbiotic Intervention
Constipation is a prevalent gastrointestinal condition. Beyond simple lifestyle measures (e.g. increasing fibre intake, …
London, United KingdomCompleted Jul 20, 2026
Sint Vincentius Ziekenhuis, Antwerp, BelgiumAZ Sint-Lucas, Bruges, BelgiumUZ Brussel, Brussels, BelgiumAntwerp University Hospital, Edegem, BelgiumAZ Maria Middelares, Ghent, BelgiumAZ Sint-Lucas, Ghent, BelgiumUZ Gent, Ghent, BelgiumUZ Leuven, Leuven, BelgiumClinical Chc Montlégia, Liège, BelgiumAZ Delta vzw, Roeselare, BelgiumBluewater Clinical Research Group Inc., Sarnia, CanadaScarborough Center for Inflammatory Bowel Disease, Scarborough, CanadaClinSurge Research - LMC Scarborough / Malvern Medical Centre, Scarborough, CanadaStouffville Medical Research Institute Inc., Stouffville, CanadaCanadian Phase Onward, Toronto, CanadaBinzhou Medical University Hospital, Binzhou, ChinaSichuan Provincial People's Hospital, Chengdu, ChinaThe First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaZhejiang Hospital of Traditioal Chinese Medicine, Hangzhou, ChinaThe Second Affiliated Hospital of University of South China, Hengyang, ChinaHuizhou Central People's Hospital, Huizhou, ChinaHuzhou Central Hospital, Huzhou, ChinaMeihekou Central Hospital, Meihekou, ChinaQuzhou People's Hospital, Quzhou, ChinaTaian City Central Hospital, Taian, ChinaXianning Central Hospital, Xianning, ChinaYichun People's Hospital, Yichun, ChinaFutureMeds GmbH, Berlin, GermanyStudienzentrum MVZ Dachau, Dachau, GermanyPratia - Hamburg, Hamburg, GermanyKlinische Forschung Karlsruhe, Karlsruhe, GermanyAmBeNet GmbH, Leipzig, GermanyFutureMeds Offenbach, Offenbach, GermanyTokyo-Eki Center-building Clinic, Chūōku, JapanSai Gastroenterology/Proctology Clinic, Fujiidera, JapanTokai University Hospital, Isehara, JapanAoyama Internal Medicine Clinic, Kobe, JapanAono Clinic, Kobe, JapanHattori Clinic - Kumamoto, Kumamoto, JapanSapporo Odori Endoscope Clinic, Sapporo, JapanNishi-Shinjuku Kisaragi Clinic, Shinjuku-Ku, JapanScientia Investigacion Clinica Tj, Ciudad de Tijuana, MexicoInvestigación Clínica Cuernavaca, S.C., Cuernavaca, MexicoClinica de Investigacion en Reumatologia y Obesidad S. C., Guadalajara, MexicoProactive CR México SA de CV, Irapuato, MexicoCentro de Investigación Clinica Chapultepec, Mexico City, MexicoHospital Juarez de Mexico, Mexico City, MexicoKohler & Milstein Research S.A. De C.V., Mérida, MexicoClinical Research Institute S.C., Tlalnepantla, MexicoCIMAB SA de CV, Torreón, MexicoNúcleo de Investigación Médica Sur de Guadalajara, Zapopan, MexicoGyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero, Katowice, PolandIRMED, Piotrkow Trybunalski, PolandTwoja Przychodnia PCM, Poznan, PolandTwoja Przychodnia SCM, Szczecin, PolandWSD MEDI, Warsaw, PolandMedical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś, Warsaw, PolandETG Zamość, Zamość, PolandHospital Universitari Vall d'Hebron, Barcelona, SpainEAP Osona Sud - Alt Congost S.L.P, Centelles, SpainHospital Universitario Virgen Nieves, Granada, SpainHospital Clinico San Carlos, Madrid, SpainHospital Universitario Puerta de Hierro Majadahonda, Madrid, SpainHospital Costa del Sol, Marbella, SpainHospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, SpainClínica Gaias - Santiago, Santiago de Compostela, SpainCheadle Community Hospital, Cheadle, United KingdomHMC Health Group - Meadows Centre for Health, Hounslow, United KingdomEMS Healthcare, Macclesfield, United KingdomRoyal Victoria Infirmary, Newcastle upon Tyne, United KingdomNewquay Health Centre, Newquay, United KingdomWoodstock Bower Surgery, Rotherham, United KingdomBrockwood Medical Practice, Surrey, United KingdomKing's Mill Hospital, Sutton in Ashfield, United KingdomRecruiting
Irritable Bowel Syndrome (IBS)
Randomized, single-blind, sham-controlled crossover study evaluating the efficacy and safety of transcutaneous auricular…
Multiple LocationsEst. completion Dec 31, 2028